D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Deferred Income Tax Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Deferred Income Tax
myr15.1m
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
16%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Deferred Income Tax
myr1m
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
N/A
A
Apex Healthcare Bhd
KLSE:AHEALTH
Deferred Income Tax
myr7.8m
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
4%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Deferred Income Tax
myr1.8m
CAGR 3-Years
65%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Deferred Income Tax
myr12.6m
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
5%
K
Kotra Industries Bhd
KLSE:KOTRA
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Duopharma Biotech Bhd's Deferred Income Tax?
Deferred Income Tax
15.1m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Deferred Income Tax amounts to 15.1m MYR.

What is Duopharma Biotech Bhd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
16%

Over the last year, the Deferred Income Tax growth was 52%. The average annual Deferred Income Tax growth rates for Duopharma Biotech Bhd have been 12% over the past three years , 6% over the past five years , and 16% over the past ten years .

Back to Top